Results 101 to 110 of about 1,241,830 (150)

[A single-center study on the distribution and antibiotic resistance of pathogens causing bloodstream infection in patients with hematological malignancies]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi, 2023
Cai LJ   +19 more
europepmc   +1 more source

2018—2022年苏州地区血流感染患儿病原菌分布和耐药性分析 附视频

open access: yesZhongguo shiyan zhenduanxue
目的 探讨苏州地区住院患儿血流感染病原菌的分布和耐药特征,为该类患者的血流感染诊治提供依据。方法 回顾性分析2018年1月至2022年12月南京医科大学附属苏州医院血培养阳性患儿的临床资料、病原菌分布及其对抗菌药物的耐药情况。结果 896例血培养阳性患儿中,新生儿719例(占80.2%),非新生儿177例(占19.8%)。在分离出的926株病原菌中,以革兰阳性菌为主(65.9%),革兰阴性菌占33.4%,真菌仅占0.8%。最常见的病原菌为表皮葡萄球菌(32.6%),其次是头状葡萄球菌 ...
doaj   +2 more sources

[Rapid detection of fluconazole resistance in <i>Candida tropicalis</i> using MALDI-TOF mass spectrometry]. [PDF]

open access: yesNan Fang Yi Ke Da Xue Xue Bao
Hou J   +5 more
europepmc   +1 more source

[Epidemiological Characteristics and Drug Resistance of Microbial Pathogens of Patients With Silicosis Combined With Pulmonary Infection]. [PDF]

open access: yesSichuan Da Xue Xue Bao Yi Xue Ban, 2023
Su MC   +7 more
europepmc   +1 more source

具有抗衰老活性的药物

open access: yes, 2006
本发明涉及具有抗衰老活性的药物,为一种或多种在20位碳上无糖基的低极性人参皂苷,具有拮抗性激素降解、提高性激素血浆水平的活性,从而发挥抗衰老的功效。该类低极性人参皂苷可以是天然或化学合成的前体化合物或衍生物经过口服后的胃酸或/和肠道菌等转化后产生的。本发明为男性PADAM和女性更年期早期提供了一种更为安全有效治疗方法。可单独使用,发挥其抗衰老的疗效,也可与目前市场上用于抗衰老的激素类和抑制前列腺增生的药物制成复方制剂,可在保持疗效的同时,减少激素类药物的用量,降低了性激素替代疗法的副作用 ...
杨 凌, 刘 勇, 何克江
core  

[Ethanol promotes oxaliplatin resistance in colorectal cancer by activating the TGF‑β/Smad/P21 signaling axis]. [PDF]

open access: yesNan Fang Yi Ke Da Xue Xue Bao
Tan B   +7 more
europepmc   +1 more source

Laboratory tools from the Fleming Fund antimicrobial resistance surveillance programme. [PDF]

open access: yesBull World Health Organ
Buhler C   +17 more
europepmc   +1 more source

[Distribution and Drug Resistance Characteristics of Pathogenic Bacteria in the Elderly Population in China in 2021]. [PDF]

open access: yesSichuan Da Xue Xue Bao Yi Xue Ban
Tang S   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy